Neurovascular Diagnostics
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$4.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neurovascular Diagnostics is a biotechnology company developing a blood-based diagnostic assay for the early detection and risk profiling of unruptured intracranial aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurovascular Diagnostics Comparables
Compare Neurovascular Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astria Biosciences, Inc. | 90% | |
| MultiplAI Health | 71% | |
| Ischemia Care | 71% | |
Neurovascular Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Grant | Jan 11, 2024 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Feb 4, 2018 | ||||
Grant | Feb 4, 2018 |
Neurovascular Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| University at Buffalo Center for Advanced Technology in Big Data and Health Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 95% MoM.
- May 18, 2026
Monthly visitors increased 1857% to 920.
Neurovascular Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurovascular Diagnostics's valuation, stock price, and market status.